Related Experiment Videos

[Laparoscopic cholecystectomy in patients previously treated with heart transplantation. A clinical case]

A Cristalli1, M M Visigalli, F Milazzo

  • 1II Servizio Anestesia e Rianimazione, Ospedale Niguarda Ca' Grande, Milano.

Insights

Laparoscopic cholecystectomy is safe and effective in heart transplant recipients. This minimally invasive surgery allows for rapid recovery and early oral intake, even in immunosuppressed patients.

Area of Science:

  • Anesthesiology
  • Transplant Surgery

Background:

  • Cardiac transplant recipients present unique anesthetic challenges due to denervated hearts and immunosuppression.
  • Cholelithiasis necessitates surgical intervention, with laparoscopic cholecystectomy being a preferred minimally invasive option.

Observation:

  • A 46-year-old patient with a history of cardiac transplantation underwent laparoscopic cholecystectomy.
  • Careful monitoring of vital parameters, particularly capnometry to manage partial pressure of carbon dioxide (paCO2), was crucial.
  • The patient's immunosuppressed status required balancing invasive monitoring with minimizing surgical invasivity.

Findings:

  • Laparoscopic cholecystectomy proceeded without complications in this denervated heart patient.
  • Effective management of paCO2 using capnometry prevented hypercapnia.
  • The patient experienced a rapid recovery, tolerating food and oral immunosuppressants within 24 hours.

Implications:

  • Laparoscopic cholecystectomy is a viable and safe surgical approach for patients with cardiac transplants.
  • Minimally invasive techniques and vigilant monitoring, including capnometry, are key to successful outcomes in this population.
  • Early recovery and discharge are achievable, improving patient experience and reducing hospital stay for immunosuppressed individuals.

Related Concept Videos